Bulletin
Investor Alert

New York Markets Close in:

ICU Medical Inc.

NAS: ICUI

GO
/marketstate/country/us

Countdown to close

 --Real time quotes

Jan 27, 2022, 3:06 p.m.

/zigman2/quotes/208026181/composite

$

204.50

Change

-4.19 -2.01%

Volume

Volume 67,332

Real time quotes

/zigman2/quotes/208026181/composite

Previous close

$ 208.69

$ 204.50

Change

-4.19 -2.01%

Day low

Day high

$203.17

$210.30

Open

52 week low

52 week high

$183.39

$282.00

Open

Company Description

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems...

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Valuation

P/E Current

51.87

P/E Ratio (with extraordinary items)

41.47

P/E Ratio (without extraordinary items)

53.31

Price to Sales Ratio

3.64

Price to Book Ratio

3.01

Price to Cash Flow Ratio

20.79

Enterprise Value to EBITDA

17.82

Enterprise Value to Sales

3.14

Total Debt to Enterprise Value

0.01

Efficiency

Revenue/Employee

160,887.00

Income Per Employee

10,996.00

Receivables Turnover

7.60

Total Asset Turnover

0.74

Liquidity

Current Ratio

4.68

Quick Ratio

3.07

Cash Ratio

2.10

Profitability

Gross Margin

36.25

Operating Margin

10.53

Pretax Margin

7.67

Net Margin

6.83

Return on Assets

5.03

Return on Equity

6.03

Return on Total Capital

9.02

Return on Invested Capital

5.89

Capital Structure

Total Debt to Total Equity

3.51

Total Debt to Total Capital

3.39

Total Debt to Total Assets

2.99

Long-Term Debt to Equity

2.89

Long-Term Debt to Total Capital

2.79

Officers and Executives

Name Age Officer Since Title
Mr. Vivek Jain 47 2014 Chairman & Chief Executive Officer
Mr. Christian Voigtlander 51 2017 Vice President-Business Development
Mr. Brian M. Bonnell - 2018 Vice President-Finance
Mr. Krishna Uppugonduri - 2015 VP-Quality, Medical & Regulatory Affairs
Ms. Virginia Sanzone 44 2015 Vice President & General Counsel

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/30/2021 Vivek Jain
Chairman and CEO; Director
1,159   Disposition at $240 per share. 278,160
12/30/2021 Vivek Jain
Chairman and CEO; Director
1,159   Derivative/Non-derivative trans. at $58.79 per share. 68,137
12/29/2021 Vivek Jain
Chairman and CEO; Director
10,677   Disposition at $240 per share. 2,562,480
12/29/2021 Vivek Jain
Chairman and CEO; Director
10,677   Derivative/Non-derivative trans. at $58.79 per share. 627,700
12/28/2021 Vivek Jain
Chairman and CEO; Director
164   Disposition at $240 per share. 39,360
12/28/2021 Vivek Jain
Chairman and CEO; Director
164   Derivative/Non-derivative trans. at $58.79 per share. 9,641
11/03/2021 Vivek Jain
Chairman and CEO; Director
12,000   Disposition at $240 per share. 2,880,000
11/03/2021 Vivek Jain
Chairman and CEO; Director
12,000   Disposition at $240 per share. 2,880,000
11/03/2021 Vivek Jain
Chairman and CEO; Director
12,000   Derivative/Non-derivative trans. at $58.79 per share. 705,480
11/03/2021 Vivek Jain
Chairman and CEO; Director
12,000   Derivative/Non-derivative trans. at $58.79 per share. 705,480
09/15/2021 Robert S. Swinney
Director
2,157   Disposition at $243 per share. 524,151
09/14/2021 George A. Lopez
Director
15,295   Derivative/Non-derivative trans. at $46.53 per share. 711,676
09/14/2021 Elisha Wade Finney
Director
2,424   Derivative/Non-derivative trans. at $101.06 per share. 244,969
09/14/2021 Elisha Wade Finney
Director
2,424   Disposition at $242.2 per share. 587,092
09/10/2021 Virginia Sanzone
VP, General Counsel
248   Disposition at $252.82 per share. 62,699
09/10/2021 Virginia Sanzone
VP, General Counsel
401   Disposition at $251.27 per share. 100,759
09/10/2021 Virginia Sanzone
VP, General Counsel
151   Disposition at $250.23 per share. 37,784
06/03/2021 Robert S. Swinney
Director
207   Disposition at $204.04 per share. 42,236
06/03/2021 Robert S. Swinney
Director
1,293   Disposition at $202.95 per share. 262,414
06/03/2021 Robert S. Swinney
Director
215   Disposition at $204.08 per share. 43,877
06/03/2021 Robert S. Swinney
Director
2,485   Disposition at $203.07 per share. 504,628
06/03/2021 Robert S. Swinney
Director
300   Disposition at $202.16 per share. 60,648
06/03/2021 Robert S. Swinney
Director
1,500   Derivative/Non-derivative trans. at $39.38 per share. 59,070
06/03/2021 Robert S. Swinney
Director
1,500   Derivative/Non-derivative trans. at $43.62 per share. 65,430
05/24/2021 Vivek Jain
Chairman and CEO; Director
40   Gift at $0 per share. 0
05/20/2021 Vivek Jain
Chairman and CEO; Director
25   Gift at $0 per share. 0
/news/latest/company/us/icui

MarketWatch News on ICUI

  1. Edwards Lifesciences Corp. stock falls Monday, underperforms market

    4:53 p.m. Jan. 24, 2022

    - MarketWatch Automation

  2. Edwards Lifesciences Corp. stock falls Friday, underperforms market

    4:53 p.m. Jan. 21, 2022

    - MarketWatch Automation

  3. Edwards Lifesciences Corp. stock falls Thursday, still outperforms market

    4:52 p.m. Jan. 20, 2022

    - MarketWatch Automation

  4. Edwards Lifesciences Corp. stock outperforms market on strong trading day

    4:53 p.m. Jan. 19, 2022

    - MarketWatch Automation

  5. Edwards Lifesciences Corp. stock falls Tuesday, underperforms market

    4:53 p.m. Jan. 18, 2022

    - MarketWatch Automation

  6. Edwards Lifesciences Corp. stock falls Friday, underperforms market

    4:53 p.m. Jan. 14, 2022

    - MarketWatch Automation

  7. Edwards Lifesciences Corp. stock rises Wednesday, still underperforms market

    4:52 p.m. Jan. 12, 2022

    - MarketWatch Automation

  8. Edwards Lifesciences Corp. stock outperforms market on strong trading day

    4:53 p.m. Jan. 11, 2022

    - MarketWatch Automation

  9. Edwards Lifesciences Corp. stock falls Thursday, underperforms market

    4:53 p.m. Jan. 6, 2022

    - MarketWatch Automation

  10. Edwards Lifesciences Corp. stock falls Wednesday, underperforms market

    4:53 p.m. Jan. 5, 2022

    - MarketWatch Automation

  11. Edwards Lifesciences Corp. stock falls Tuesday, underperforms market

    4:53 p.m. Jan. 4, 2022

    - MarketWatch Automation

  12. Edwards Lifesciences Corp. stock falls Monday, underperforms market

    4:53 p.m. Jan. 3, 2022

    - MarketWatch Automation

  13. Edwards Lifesciences Corp. stock falls Friday, underperforms market

    4:52 p.m. Dec. 31, 2021

    - MarketWatch Automation

  14. Edwards Lifesciences Corp. stock rises Thursday, outperforms market

    4:52 p.m. Dec. 30, 2021

    - MarketWatch Automation

  15. Loading more headlines...
/news/nonmarketwatch/company/us/icui

Other News on ICUI

  1. Some Companies Are Ready for Libor’s Demise, but Not All

    6:16 a.m. Dec. 31, 2021

    - The Wall Street Journal Interactive Edition

  2. 3 Companies Growing Revenue Per Share Fast

    9:58 a.m. Nov. 19, 2021

    - GuruFocus.com

  3. 10-Q: ICU MEDICAL INC/DE

    4:04 p.m. Nov. 5, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  4. ICU Medical, inc (ICUI) Q3 2021 Earnings Call Transcript

    8:31 p.m. Nov. 3, 2021

    - Motley Fool

  5. Company News for Sep 9, 2021

    8:34 a.m. Sept. 9, 2021

    - Zacks.com

  6. Why ICU Medical Stock Is Jumping Today

    3:17 p.m. Sept. 8, 2021

    - Motley Fool

  7. GSAT, ATER and PXLW among mid-day movers

    12:29 p.m. Sept. 8, 2021

    - Seeking Alpha

  8. ICU Medical to acquire Smiths Group Medical division for $2.35B

    5:08 a.m. Sept. 8, 2021

    - Seeking Alpha

  9. Loading more headlines...

At a Glance

ICU Medical, Inc.

951 Calle Amanecer

San Clemente, California 92673-6212

Phone

1 9493662183

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2021

Revenue

$1.27B

Net Income

$86.87M

2020 Sales Growth

0.4%

Employees

7,900

/news/pressrelease/company/us/icui

Press Releases on ICUI

  1. ICU Medical, Inc. Announces Third Quarter 2021 Results

    3:05 p.m. Nov. 3, 2021

    - GlobeNewswire

  2. Loading more headlines...
Trending Tickers
  • /zigman2/quotes/207505872/composite DISH+1.05%
  • /zigman2/quotes/204151124/composite CURE-1.23%
  • /zigman2/quotes/214908404/composite GFL+1.15%
  • /zigman2/quotes/204236046/composite DUST+1.32%
  • /zigman2/quotes/200683073/composite FRC+0.90%
X
Powered by StockTwits
Link to MarketWatch's Slice.